INCY vs MEDP
Incyte Corp (INCY) and Medpace Holdings, Inc. (MEDP) are both filed with the SEC under Services-Commercial Physical & Biological Research. INCY is 1.5× MEDP's size by market cap ($25.5B against $17.1B); MEDP trades at the higher fiscal-year P/E (40.0× against 19.9×); INCY reports the higher net margin (25.0% against 17.8%); MEDP grew sales faster over three years (+20.1% against +14.8%); and over the past year INCY returned +48.6% against MEDP's +27.0%.
| INCY | MEDP | |
|---|---|---|
| Last close | $124.37 | $600.65 |
| Market cap | $25.5B | $17.1B |
| P/E (FY) | 19.9× | 40.0× |
| P/S | 5.0× | 6.7× |
| Operating margin | 29.5% | 21.1% |
| Net margin | 25.0% | 17.8% |
| Return on equity | 29.9% | 70.2% |
| Sales growth (3y) | +14.8% | +20.1% |
| EPS growth (3y) | +61.6% | +28.0% |
| 1-year return | +48.6% | +27.0% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year — FY2025 (ended 2025-12-31) for both.
Who holds them, and who has traded them
| INCY | MEDP | |
|---|---|---|
| Institutional holders (13F) | 809 | 726 |
| Insider buyers − sellers (180d) | -3 | -2 |
| Congressional trades disclosed (180d) | 0 | 2 |
| Executive-branch officials on file — trades disclosed (180d) | 0 | 0 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5.
INCY vs MEDP: common questions
- Is INCY bigger than MEDP?
- INCY carries the larger market cap — $25.5B against $17.1B, both struck on 2026-08-27.
- Which trades at a higher P/E, INCY or MEDP?
- MEDP, at a fiscal-year 40.0× against 19.9× for INCY. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have INCY and MEDP performed over the past year?
- INCY returned +48.6% and MEDP +27.0%, measured on the trailing calendar year to the last close.
- How many institutions hold INCY and MEDP?
- 809 13F filers report a position in INCY and 726 in MEDP, on the latest quarter in the panel.
- Are INCY and MEDP in the same industry?
- Both are filed with the SEC under Services-Commercial Physical & Biological Research, which is the classification this pairing is built on.
INCY overview → · MEDP overview → · INCY institutional ownership → · MEDP institutional ownership → · Congress and MEDP →
More in Services-Commercial Physical & Biological Research: INCY vs IQV · IQV vs MEDP
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/incy-vs-medp